SALIX PHARMACEUTICALS LTD — Form D

SALIX PHARMACEUTICALS LTD of Raleigh, NC, a company, filed a Form D exempt-offering notice with the SEC on 2014-01-10. The offering totals $750.0M, of which $750.0M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2014-01-10
• Form: D
• Accession: 0001209191-14-002846
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $750.0M
• Amount sold: $750.0M
• Investors: 7
• Date of first sale: 2013-12-27
• Security types: debt
• Revenue range: Over $100,000,000
• SEC file number: 021-209813

Issuer

• Name: SALIX PHARMACEUTICALS LTD
• CIK: 0001009356
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 8510 Colonnade Center Drive, Raleigh, NC, 27615
• Phone: 919-862-1000

Officers, directors & promoters (9)

More

• CIK 1009356 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search